Inogen (INGN) EBITDA (2013 - 2026)
Inogen (INGN) posted quarterly EBITDA of -$9.3 million for Q1 2026, down 21.94% year-over-year from -$12.0 million in Q1 2025, and little changed quarter-over-quarter from -$9.3 million in Q4 2025.
Inogen (INGN) EBITDA (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported EBITDA for 14 consecutive years, with -$9.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA fell 21.94% year-over-year to -$9.3 million; the TTM figure through Mar 2026 stood at -$31.9 million (up 5.93% YoY), while the FY2025 annual figure was -$30.2 million, up 28.95% from the prior year.
- EBITDA was little changed at -$9.3 million in Q1 2026 per INGN's latest filing, from -$9.3 million in the prior quarter.
- Across five years, EBITDA topped out at -$2.9 million in Q2 2022 and bottomed at -$58.5 million in Q4 2022.
- Historically, EBITDA has averaged -$16.3 million across 5 years, with a median of -$10.3 million in 2022.
- Annual changes were most pronounced in 2022 — EBITDA slumped 776.5% — and 2024, when it jumped 83.32%.
- Inogen's EBITDA stood at -$58.5 million in 2022, then jumped by 50.45% to -$29.0 million in 2023, then surged by 60.71% to -$11.4 million in 2024, then advanced by 18.27% to -$9.3 million in 2025, then decreased by 0.32% to -$9.3 million in 2026.
- Business Quant data shows INGN's EBITDA at -$9.3 million in Q1 2026, -$9.3 million in Q4 2025, and -$7.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Inogen | 153.08 Mn | 47.54 Mn | 43.27 Mn | -5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.10 Mn |
| Mar 31, 2026 | -9.34 Mn |
| Dec 31, 2025 | -9.31 Mn |
| Sep 30, 2025 | -7.12 Mn |
| Jun 30, 2025 | -6.13 Mn |
| Mar 31, 2025 | -7.66 Mn |
| Dec 31, 2024 | -11.39 Mn |
| Sep 30, 2024 | -7.79 Mn |
| Jun 30, 2024 | -7.06 Mn |
| Mar 31, 2024 | -16.27 Mn |
| Dec 31, 2023 | -28.98 Mn |
| Sep 30, 2023 | -46.72 Mn |
| Jun 30, 2023 | -11.77 Mn |
| Mar 31, 2023 | -21.92 Mn |
| Dec 31, 2022 | -58.49 Mn |
| Sep 30, 2022 | -10.29 Mn |
| Jun 30, 2022 | -2.88 Mn |
| Mar 31, 2022 | -13.59 Mn |
| Dec 31, 2021 | -6.67 Mn |
| Sep 30, 2021 | 6.37 Mn |